ReviewNature reviews. Clinical oncology2024
BRAF - a tumour-agnostic drug target with lineage-specific dependencies.
Aphrothiti J Hanrahan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
70 papers cite itlatest 60 shown
this paperpooled ittrialcites it